Brief: Veru Reaches Agreement With FDA On Confirmatory Phase 3 Clinical Trial

Veru

04/05/2023 13:41

May 4 (Reuters) - Veru Inc  VERU.O :
    * VERU REACHES AGREEMENT WITH FDA ON CONFIRMATORY PHASE 3
CLINICAL
TRIAL FOR SABIZABULIN TREATMENT OF HOSPITALIZED COVID-19 ADULT
PATIENTS AT HIGH RISK FOR ARDS
    * VERU INC: ENROLLMENT IS EXPECTED TO INITIATE IN SECOND
HALF OF
2023 AND FIRST PLANNED INTERIM EFFICACY ANALYSIS EXPECTED IN
2024

Source text for Eikon:  ID:nGNX3vYPxR 
Further company coverage:  VERU.O